HIGHLIGHTS
- who: Ying Ma and collaborators from the Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China have published the research: Association between Pre-Existing Long-Term -Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study, in the Journal: Medicina 2022, 58, 1843. of 13/Nov/2022
- what: The authors aimed to assess the potential and the outcomes of patients with SAC. This study showed that long-term u03b2-blocker therapy was related to substantially lower levels of DD and a trend of improved APTT in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.